{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T11:23:31Z","timestamp":1744025011829},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-018-1231-3","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T11:30:32Z","timestamp":1545046232000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence"],"prefix":"10.1186","volume":"16","author":[{"given":"Chester B.","family":"Good","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"1231_CR1","doi-asserted-by":"crossref","unstructured":"De Boer PT, van Lier A, de Melker H, van Wijck AJM, Wilschut JC, van Hoek AJ, et al. Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccine. BMC Med. 2018; \n                    https:\/\/doi.org\/10.1186\/s12916-018-1213\u20135\n                    \n                  . Accessed 11 Dec 2018.","DOI":"10.1186\/s12916-018-1213-5"},{"key":"1231_CR2","unstructured":"U.S. Department of Health and Human Services. What everyone should know about Zostavax. 2018. \n                    https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/public\/zostavax\/index.html\n                    \n                  . Accessed 15 Nov 2018."},{"key":"1231_CR3","unstructured":"European Medicines Agency. Zostavax. 2018. \n                    https:\/\/www.ema.europa.eu\/medicines\/human\/EPAR\/zostavax#authorisation-details-section\n                    \n                  . Accessed 15 Nov 2018."},{"key":"1231_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341.","journal-title":"Mayo Clin Proc."},{"key":"1231_CR5","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271\u201384.","journal-title":"N Engl J Med."},{"key":"1231_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/cid\/ciu918","volume":"60","author":"VA Morrison","year":"2015","unstructured":"Morrison VA, Johnson GR, Schmader KE, et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis. 2015;60:900\u20139.","journal-title":"Clin Infect Dis."},{"key":"1231_CR7","first-page":"89","volume":"357","author":"CB Good","year":"2007","unstructured":"Good CB. Varicella-zoster vaccine. N Engl J Med. 2007;357:89.","journal-title":"N Engl J Med."},{"key":"1231_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1056\/NEJMc076176","volume":"357","author":"EJ Woo","year":"2007","unstructured":"Woo EJ, Ball R, Barun MM. Varicella-zoster vaccine. N Engl J Med. 2007;357:88.","journal-title":"N Engl J Med."},{"key":"1231_CR9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/cid\/cir970","volume":"54","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years. Clin Infect Dis. 2012;54:922\u20138.","journal-title":"Clin Infect Dis."},{"key":"1231_CR10","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.amepre.2016.08.029","volume":"52","author":"D Zhang","year":"2017","unstructured":"Zhang D, Johnson K, Newransky C, Acosta CJ. Herpes zoster vaccine coverage in older adults in the U.S., 2007\u20132013. Am J Prev Med. 2017;52:e17\u201323.","journal-title":"Am J Prev Med."},{"key":"1231_CR11","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chilbek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087\u201396.","journal-title":"N Engl J Med."},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Chlibek KR. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age and older. N Engl J Med. 2016;375:1019\u201332.","journal-title":"N Engl J Med."},{"key":"1231_CR13","doi-asserted-by":"publisher","first-page":"S389","DOI":"10.2105\/AJPH.2008.151332","volume":"99","author":"JC Nelson","year":"2009","unstructured":"Nelson JC, Bittner RC, Bounds L, Zhoa S, Baggs J, Donahue JG, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009;99:S389\u201397.","journal-title":"Am J Public Health."},{"key":"1231_CR14","doi-asserted-by":"crossref","unstructured":"Weinberg A, Popmihajlov Z, Schmader KE, Johnson MJ, Caldas Y, Salazar A, et al. Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of liver herpes zoster vaccine. J Infect Dis. 2018; \n                    https:\/\/doi.org\/10.1093\/infdis\/JIY514\n                    \n                  . Accessed 11 Dec 2018.","DOI":"10.1093\/infdis\/jiy514"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-018-1231-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T19:15:10Z","timestamp":1576610110000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-018-1231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1186\/s12916-018-1231-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript does not report research results so institutional review approval was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CBG and NP are employees of the Insurance Services Division, at the University of Pittsburgh School of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"238"}}